Selected article for: "acute respiratory failure and lung function"
Author: Andreakos, Evangelos; Papadaki, Maria; Serhan, Charles N.
Title: Dexamethasone, pro‐resolving lipid mediators and resolution of inflammation in COVID‐19
  • Cord-id: k4mlkhu6
  • Document date: 2020_9_21
    • ID: k4mlkhu6
    Snippet: Coronavirus disease‐19 (COVID‐19) is a new disease caused by SARS‐CoV‐2. Since the beginning of 2020, it has become one of the main challenges of our times, causing a high incidence of severe pneumonia, acute respiratory distress syndrome (ARDS), multiorgan failure and death(1). At the root of COVID‐19 lies the sudden development of ‘cytokine storms’, hyper‐inflammatory responses involving the release of pro‐inflammatory cytokines (e.g., TNF, IL‐6, IL‐1, IL‐8, and MCP‐1
    Document: Coronavirus disease‐19 (COVID‐19) is a new disease caused by SARS‐CoV‐2. Since the beginning of 2020, it has become one of the main challenges of our times, causing a high incidence of severe pneumonia, acute respiratory distress syndrome (ARDS), multiorgan failure and death(1). At the root of COVID‐19 lies the sudden development of ‘cytokine storms’, hyper‐inflammatory responses involving the release of pro‐inflammatory cytokines (e.g., TNF, IL‐6, IL‐1, IL‐8, and MCP‐1) that impair the gas exchange function of the lung and lead in select patients, mostly with underlying comorbidities, to multiorgan failure and death.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and lymphocyte macrophage: 1, 2
    • acute ards respiratory distress syndrome and lymphocyte macrophage neutrophil: 1